SecBot SecBot
Insider Cluster (6 insiders) ·Filed Aug 11, 2026

TWST

Twist Bioscience Corp
NEUTRAL
Impact 4/10
Horizonweeks Processed3mo ago
Insider cluster: 6 insiders, $4.4M total
Actionable Insight • Neutral

The insider sales are likely liquidity-driven (option exercises, vesting) given the small size relative to market cap and the strong earnings backdrop. Monitor for any follow-on sales by CEO Leproust or COO Finn in the next 30 days, a repeat at similar or larger size would elevate the signal. The bullish earnings catalyst (raised guidance, margin expansion) remains the dominant narrative; these sales do not negate it.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$125.21
T+0 close · Aug 11, 2026 · via day close
Latest settled
+13.87%
T+60 · $142.58
Vs SPY
+18.75%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 12 $125.21entry
  2. T+1 · 3mo ago +0.06%α −0.63% · $125.29
  3. T+5 · 3mo ago +13.72%α +14.16% · $142.39
  4. T+20 · 2mo ago +1.31%α +3.21% · $126.85
  5. T+60 · 12d ago +13.87%α +18.75% · $142.58
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A cluster of insider sales at Twist Bioscience totaling $4.39M occurred within 9 days of a strong Q3 2026 earnings beat and raised guidance. The sales include CEO Emily Leproust ($435K), President/COO Patrick Finn ($246K), and Director Robert Chess ($2.04M, following option exercises). While the earnings report was bullish (revenue +23% YoY, guidance raised), the insider selling cluster, particularly the CEO's open-market sale, introduces a cautionary signal that partially offsets the positive fundamental momentum. The total sale value represents ~0.05% of the $8.2B market cap, which is below the 0.1% materiality threshold, suggesting these are routine liquidity-driven sales rather than informed bearish bets, especially given the stock's 94% analyst bullish consensus and strong historical performance.

Key Financial Metrics

Direction
selling
Total Value
$4.4M
Insiders
6

Key Facts

  • Insider cluster of 6 sales totaling $4.39M over 7 days (Aug 1-7, 2026)
  • CEO Emily Leproust sold $435K in open-market shares on Aug 3
  • Director Robert Chess sold $2.04M on Aug 7 after exercising options at $11.89
  • Sales occurred 9 days after Twist reported Q3 FY2026 revenue of $118.4M (+23% YoY, beat consensus) and raised FY guidance to $456-457M
  • Total sale value is ~0.05% of $8.2B market cap, below the 0.1% materiality threshold for insider clusters

Financial Impact

Insider sales of $4.39M represent 0.05% of market cap, routine and non-material

insider ownershipdilution

Risk Factors

  • CEO open-market sale could signal peak valuation sentiment if repeated
  • Director Chess's sale after option exercise may indicate diversification, not bearish view
  • Cluster sales are weakly predictive per academic literature, liquidity-driven, not informational

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TWST-1786525460694

US Market Status

Market Closed · Opens Wed (14h 25m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 12, 2026